Furthermore, treatment with the GRPR antagonist of nude mice with xenografts of U-87MG decreased the tumor size by 60%, also decreased the c-fos levels by 30–40%, leading the authors to suggest that downregulation of the c-fos oncogene by the GRP antagonism could be one of the mechanisms for its antigrowth effects. This evidence concerns the gene GRP and neoplasm.